Citius Oncology (CTOR)

Profile

Full Name

Citius Oncology, Inc.

Ticker Symbol

CTOR

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

Indexes

Not included

Website

Employees

-

Key Details

Price

$0.64(-6.81%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.31(-73.96% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.64
CTOR price is $0.64

30-Day Relative Volume

0.78
CTOR 30-day relative volume is 0.78

Price Performance

Price Today change

-6.81%
CTOR price is down -6.81% today

Price YTD change

-44.65%
CTOR price is down -44.65% since January 1st

Price 1-year change

-94.27%
CTOR price is down -94.27% year-on-year

Price 3-year change

-
CTOR price 3-year change is unknown

Price Range

Price All-time high

$49.00
CTOR price is currently -98.70% below its historical high of $49.00

Price 3-year low

$0.55
CTOR price is currently +15.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.54M
CTOR market capitalization is $45.54 million

Market cap 3-year change

-
CTOR market capitalization 3-year change is unknown

Market cap All-time high

$2.89B
CTOR market capitalization is currently -98.42% below its historical high of $2.89 billion

Market cap sector rank

37.01%
CTOR market capitalization is higher than 37.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.44%
CTOR shares outstanding is up +0.44% year-on-year

Shares Outstanding 3-Year Change

-
CTOR shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-1.31
CTOR beta is -1.31

200-day SMA

$3.63
CTOR price is currently -82.48% below its 200-day simple moving average

50-day SMA

$0.92
CTOR price is currently -30.73% below its 50-day simple moving average

RSI

44.40
CTOR 14-day relative strength index is 44.40

Volume

0.78
CTOR 30-day relative volume is 0.78

ATR

$0.12
CTOR average true range is $0.12

10-day Historical Volatility

95.15%
CTOR 10-day historical volatility is 95.15%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CTOR annual revenue value is unknown

Revenue Analysts estimate

$28.68M
CTOR annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CTOR annual revenue 1-year change is unknown

Revenue Sector rank

-
CTOR annual revenue is unknown

EPS

EPS

-$0.31
CTOR annual earnings per share is -$0.31

EPS Analysts estimate

-
CTOR annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-73.96%
CTOR annual earnings per share is down -73.96% year-on-year

EPS Sector rank

74.32%
CTOR annual earnings per share is higher than 74.32% of companies in Healthcare sector

Profit

Gross profit

-
CTOR annual gross profit value is unknown

Gross margin

-
CTOR annual gross profit margin value is unknown

Operating profit

-$20.57M
CTOR annual operating income is -$20.57 million

Operating margin

-
CTOR annual operating profit margin value is unknown

Net income

-$21.15M
CTOR annual net profit is -$21.15 million

Net margin

-
CTOR annual net profit margin value is unknown

Expenses

Total expenses

$20.57M
CTOR annual total expenses is $20.57 million

Operating expenses

$20.57M
CTOR annual total operating expenses is $20.57 million

Cost of goods sold

-
CTOR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$15.65M
CTOR annual SGA is $15.65 million

Depreciation and amortization

-
CTOR annual depreciation & amortization value is unknown

Interest expense

-
CTOR annual interest expense value is unknown

Income tax

$576.00K
CTOR annual income tax is $576.00 thousand

EBIT & EBITDA

EBIT

-$20.57M
CTOR annual earnings before interest & taxes is -$20.57 million

EBITDA

-$20.57M
CTOR annual EBITDA is -$20.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$84.37M
CTOR annual total assets is $84.37 million

Non current assets

$73.40M
CTOR annual long term assets is $73.40 million

Current assets

$10.97M
CTOR annual total current assets is $10.97 million

Cash and cash equivalents

$100.00
CTOR annual cash & cash equivalents is $100.00

Accounts receivable

-
CTOR annual accounts receivable value is unknown

Inventory

$8.27M
CTOR annual inventory is $8.27 million

Liabilities

Total liabilities

$38.23M
CTOR annual total liabilities is $38.23 million

Long term liabilities

$5.53M
CTOR annual total long term liabilities is $5.53 million

Current liabilities

$32.70M
CTOR annual total current liabilities is $32.70 million

Accounts payable

$3.71M
CTOR annual accounts payable is $3.71 million

Debt

Total debt

$3.80M
CTOR annual total debt is $3.80 million

Total debt 1-year change

+100%
CTOR annual total debt is up +100% year-on-year

Long term debt

$3.80M
CTOR annual long term debt is $3.80 million

Short term debt

-
CTOR annual short term debt value is unknown

Equity & Capital

Shareholders equity

$46.14M
CTOR annual stockholders equity is $46.14 million

Book value

$46.14M
CTOR annual book value is $46.14 million

Retained earnings

-$39.28M
CTOR annual retained earnings is -$39.28 million

Working capital

-$21.73M
CTOR annual working capital is -$21.73 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$126.40K
CTOR annual cash flow from operations is $126.40 thousand

Cash from operations 1-year change

+100%
CTOR annual cash flow from operations is up +100% year-on-year

Cash from investing

-$5.00M
CTOR annual cash flow from investing activities is -$5.00 million

Cash from investing 1-year change

-100%
CTOR annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$4.87M
CTOR annual cash flow from financing activities is $4.87 million

Cash from financing 1-year change

+100%
CTOR annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

-
CTOR annual capital expenditures value is unknown

CAPEX 1-year change

-
CTOR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.87M
CTOR annual free cash flow is -$4.87 million

Free cash flow 1-year change

-100%
CTOR annual free cash flow is down -100% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CTOR annual gross profit margin value is unknown

Operating margin

-
CTOR annual operating profit margin value is unknown

Net margin

-
CTOR annual net profit margin value is unknown

ROA & ROE

ROA

-25.07%
CTOR annual return on assets is -25.07%

ROE

-45.84%
CTOR annual return on equity is -45.84%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CTOR price to earnings ratio value is unknown

PE ratio Sector rank

-
CTOR price to earnings ratio is unknown

PB Ratio

PB ratio

1.10
CTOR price to book ratio is 1.10

PB ratio Sector rank

46.34%
CTOR price to book ratio is higher than 46.34% of companies in Healthcare sector

PS Ratio

PS ratio

-
CTOR price to sales ratio value is unknown

PS ratio Sector rank

-
CTOR price to sales ratio is unknown

Enterprise value

Enterprise value

$49.34M
CTOR enterprise value is $49.34 million

Enterprise value Sector rank

41.36%
CTOR enterprise value is higher than 41.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.72
CTOR EV/EBITDA is -7.72

EV/EBITDA Sector rank

13.49%
CTOR EV/EBITDA is higher than 13.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.34
CTOR annual current ratio is 0.34

Quick ratio

0.08
CTOR annual quick ratio is 0.08

Leverage

Debt to equity

0.08
CTOR annual debt to equity ratio is 0.08

Interest coverage ratio

-
CTOR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CTOR piotroski f-score value is unknown

Altman Z-Score

-
CTOR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 27, 24 Maxim Group
Buy
Aug 13, 24 EF Hutton
Buy

Institutional Ownership

Similar stocks

ATHE logo
Alterity Therapeutics Limited (ATHE)
ACET logo
Adicet Bio (ACET)
BYSI logo
BeyondSpring (BYSI)
ZOM logo
Zomedica (ZOM)
STRO logo
Sutro Biopharma (STRO)
VTVT logo
vTv Therapeutics (VTVT)
ICCC logo
ImmuCell (ICCC)
ONCY logo
Oncolytics Biotech (ONCY)
CUE logo
Cue Biopharma (CUE)
  • What is the ticker symbol for Citius Oncology?
  • Does Citius Oncology pay dividends?
  • What sector is Citius Oncology in?
  • What industry is Citius Oncology in?
  • What country is Citius Oncology based in?
  • Is Citius Oncology in the S&P 500?
  • Is Citius Oncology in the NASDAQ 100?
  • Is Citius Oncology in the Dow Jones?
  • When was Citius Oncology's last earnings report?
  • When does Citius Oncology report earnings?
  • Should I buy Citius Oncology stock now?

What is the ticker symbol for Citius Oncology?

The ticker symbol for Citius Oncology is NASDAQ:CTOR

Does Citius Oncology pay dividends?

No, Citius Oncology does not pay dividends

What sector is Citius Oncology in?

Citius Oncology is in the Healthcare sector

What industry is Citius Oncology in?

Citius Oncology is in the Drug Manufacturers - Specialty & Generic industry

What country is Citius Oncology based in?

Citius Oncology is headquartered in United States

Is Citius Oncology in the S&P 500?

No, Citius Oncology is not included in the S&P 500 index

Is Citius Oncology in the NASDAQ 100?

No, Citius Oncology is not included in the NASDAQ 100 index

Is Citius Oncology in the Dow Jones?

No, Citius Oncology is not included in the Dow Jones index

When was Citius Oncology's last earnings report?

Citius Oncology's most recent earnings report was on Feb 14, 2025

When does Citius Oncology report earnings?

The next expected earnings date for Citius Oncology is Aug 8, 2025

Should I buy Citius Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page